Search
for

    Glossary Goserelin

    reduces sex hormone production to treat hormone-sensitive cancers

    Goserelin, also known by the brand name Zoladex, is a type of medication called a gonadotropin-releasing hormone (GnRH) agonist. It is used to treat hormone-sensitive cancers such as prostate cancer in men and breast cancer in premenopausal women, as well as certain benign gynecological conditions like endometriosis. Goserelin works by reducing the production of sex hormones (testosterone and estrogen), which can help slow the growth of hormone-dependent tumors.

    Research 7 of 110

    1. An Open Randomized Comparative Study of an Oral Contraceptive Containing Ethinyl Estradiol and Cyproterone Acetate with and without the GnRH Analogue Goserelin in the Long-Term Treatment of Hirsutism Gynecologic and obstetric investigation · 2010 · 18 citations
    2. Effect of the gonadotrophin releasing hormone analogue, goserelin, and oestradiol replacement on sebum excretion rates and hair size in mildly hirsute women Journal of dermatological treatment · 1991 · 4 citations
    3. Enzalutamide/finasteride/goserelin/zoledronic-acid Reactions Weekly · 2024
    4. Frontal fibrosing alopecia after antiandrogen hormonal therapy in a male patient Journal of the European Academy of Dermatology and Venereology · 2018 · 9 citations
    5. (PNM-35) Recurrent priapism in a sickle cell disease patient treated with gonadotropin-releasing hormone (GnRH) agonists drugs: a case report The Journal of Sexual Medicine · 2026
    6. SUN-106 Nonsurgical Management of Hyperandrogenism in a Postmenopausal Woman Journal of the Endocrine Society · 2025
    7. Slow progress in prostate cancer BJUI · 2007
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →